Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Neoplasms, Breast
Interventions: DRUG: Lapatinib in combination with an anti-cancer agent|DRUG: Lapatinib|DRUG: Lapatinib in combination with an anti-cancer agent as specified by parent protocol
Sponsor: Novartis Pharmaceuticals